U.S., Oct. 29 -- An application to own the trademark for 'ATLYPHE' has been filed on Mar. 14, 2024.
Owner(s):
ATLyphe AG; c/o ETH Zürich, Wyss Zurich,, Translational Center, Weinbergstrasse 35, WEH F 14 CH-8092 Zürich ETH-Zentrum, SWITZERLAND
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of blood disorders, cardiovascular disorders, metabolic and endocrine disorders, immune system related diseases and disorders, oncological disorders, neurological disorders, infectious diseases, pain, inflammation; medical preparations for the treatment of blood disorders, cardiovascular disorders, metabolic and endocrine disorders, immune system related diseases and disorders, oncological disorders, neurological disorders, i...